Bruno Daniele

13PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|Jun 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora

|Jan 21, 2023
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.

Rodolfo Sacco, Daryl Ramai, Raffaella Tortora

|Jan 08, 2023
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience.

Massimiliano Salati, Michele Ghidini, Matteo Paccagnella

|Dec 23, 2022
Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact.

Piera Federico, Emilio Francesco Giunta, Andrea Tufo

|Aug 12, 2022
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy.

Pasquale Pisapia, Antonino Iaccarino, Caterina De Luca

Pageof 3

Frequent Collaborators

7 joint publications

Emilio Francesco Giunta

6 joint publications

Piera Federico

5 joint publications

Angelica Petrillo

5 joint publications

Margaret Ottaviano